
2 Minutes with Joey - PFE Stock News
A quick daily recap of Pfizer (PFE) stock performance, explaining what the stock did and why in plain English. The podcast is for information and entertainment only, not financial advice.
Episodes

PFE Today - Aug 13: CEO Buys Stock
Hey there! It’s Joey, your friendly stock enthusiast, here to break down what happened with Pfizer today. So, PFE had a pretty solid day, up about 1.5%. Not too shabby, right? Now, let’s get into it. The big news was that Pfizer’s CEO decided to drop a cool million on some company stock. That’s a bold move, and it definitely got some folks talking. When the head honcho puts their money where their

PFE Today - Aug 12: Lagging Stock Performance
Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for ya. Today, we’re talking about Pfizer, or PFE, and it had a rough go, closing the day in the red, down about 1.3%. Ouch.So, what went down? Well, PFE got smoked today. There’s been a lot of chatter about their stock lagging behind the competition, and it’s pretty clear that investors weren’t feeling it. Peopl

PFE Today - Aug 11: Earnings Decline Sparks Concerns
Hey there! It’s Joey, your friendly neighborhood investor. Today, we’re talking about Pfizer, and it was a red day for them. The stock dipped about half a percent. Ouch!So here’s the scoop. Pfizer’s been on a bit of a rollercoaster lately. Today’s drop follows a pretty rough earnings report where they revealed their earnings have tanked by 58% this year. Yeah, that one stung. Investors are getting

PFE Today - Aug 10: Strong Q2 Results Boost Stock
Hey there! It's Joey here, your friendly neighborhood investor, breaking down the day’s action. Today we're chatting about Pfizer, and it was a green day for them! The stock was up a little over a third of a percent. Not huge, but hey, green is good, right?So, what happened? Pfizer's been riding a bit of a wave after dropping their Q2 results. They jumped almost 7% right after those numbers came o

PFE Today - Aug 09: Pfizer's Earnings Beat Sparks Interest
Hey, what’s up? It’s Joey here, your friendly investor buddy, breaking down the day for you. Today we’re talking about Pfizer, and guess what? It had a pretty solid green day, up about 2%. So, here’s the scoop. Pfizer's stock caught some good vibes today, moving higher after they reported their earnings. They actually beat the estimates, which is always a nice surprise, right? And they’re eyeing s

PFE Today - Aug 08: Pfizer's Lyme Vaccine Shines
Hey there! It’s Joey, your friendly stock guy, and I’ve been in the investing game for a while now. Today, we’re talking about Pfizer, and it was a green day – nice to see that 2.06% bump!So, what went down? Pfizer’s stock got a little boost today, moving up a bit, and you know what? It actually outperformed some of its competitors. That's always a nice surprise. Traders were definitely feeling a

PFE Today - Aug 07: Earnings Beat, Stock Slips
Hey there! It’s Joey, your friendly longtime investor, here to break down the day. Today we’re talking about Pfizer, and it was a red day for them. The stock slipped about three-quarters of a percent. So, what went down? Pfizer’s earnings report was actually pretty solid. They beat expectations, which usually gets folks hyped, but today, that wasn’t enough. The stock got hit, even with their annou

PFE Today - Aug 06: Earnings Beat, Stock Still Slips
Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Pfizer today. So, PFE had a bit of a red day, barely up at 0.62%. Now, here’s the scoop. Pfizer’s been all over the place lately. They reported earnings that actually beat expectations, which usually gives stocks a nice little boost, right? But instead of soaring, it kinda just hung around. People wer

PFE Today - Aug 05: Covid Pill Revenue Plummets
Hey there! I'm Joey, your friendly neighborhood investor. Today, we’re talking about Pfizer, and it was a bit of a rough ride—down just a smidge, like barely 0.04%. Not a huge drop, but still, a red day.So, what went down? Pfizer's stock didn’t really move much, even though there was a big story about their Covid pill revenue crashing—like, down 95%. Ouch. But here’s the kicker: despite that massi

PFE Today - Aug 04: Covid Pill Revenue Plunges
Hey, what’s up? It’s Joey here, your friendly stock guy, and I’ve been investing for a minute. Today we’re talking about Pfizer, and it was a bit of a red day for them, down about half a percent. Not the end of the world, but yeah, it wasn’t great.So, what went down? Pfizer’s stock kinda got smoked today, mainly because their Covid pill revenue took a massive hit—like, a 95% drop. Ouch! That’s a b

PFE Today - Aug 03: Lyme Vaccine Shows Promise
Hey there! It's Joey, your friendly longtime investor, here to break down the day for Pfizer. So, PFE had a bit of a chill day, barely moving, just up a tiny bit—like 0.34%. What happened? Well, the stock didn’t really make any big moves today. It was kind of a slow bleed, you know? Nothing too dramatic on the charts. But here’s what’s interesting—Pfizer’s Lyme disease vaccine showed some solid nu

PFE Today - Aug 02: Slight Gain Before Earnings
Hey there! It’s Joey, your friendly investor buddy, breaking down the day for you. Today, we’re chatting about Pfizer — and guess what? It was a green day! The stock ticked up about 0.4%. Not a huge jump, but hey, it’s better than getting smoked.So, what went down? Pfizer’s stock kinda just floated up a bit. There was a lot of buzz around the company as folks are gearing up for their Q2 earnings r

PFE Today - Aug 01: Mixed Signals Ahead
Hey there! It’s Joey, your go-to guy for stock chatter. I’ve been in this game for years, and today we’re looking at Pfizer, or PFE, and guess what? It was a bit of a slow day, barely up 0.4%. Not exactly fireworks, right? So, here’s the scoop. Pfizer’s stock kinda floated around today, not too much movement. It opened, did its thing, and closed right around $25.01. Volume was pretty steady, just

PFE Today - Jul 31: Lyme Vaccine News
Hey there! It’s Joey here, your friendly neighborhood investor. Today, I’m breaking down Pfizer, or PFE as we like to call it. It was a bit of a flat day, down just a smidge, like 0.3%. Not a huge deal, but still a red day.So, what went down? Well, the stock didn’t really budge much, hanging around that $24.83 mark. It’s like it was just chillin’ there, not making any big moves. Volume was steady,

PFE Today - Jul 30: Earnings Ahead, Stock Slips
Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for you. Today, we’re talking about Pfizer, and it was a red day for them, down about 2.25%. Ouch!So, what went down? Well, PFE got smoked today, slipping in price and leaving some folks scratching their heads. The stock was pretty steady for a bit but then just couldn’t hold onto its gains. Now, why did this happen?

PFE Today - Jul 29: Weaker Earnings, Strong Pipeline
Hey there! It’s Joey, your friendly stock buddy, and I’ve been in the investing game for years. Today, let’s talk about Pfizer, or PFE if you’re into the tickers. It was a pretty chill day for the stock—barely moved, just hanging out at the same price.So, what went down? The stock didn’t really budge, like it was stuck in neutral. Volume was steady but nothing crazy. It’s like the market was waiti

PFE Today - Jul 28: Earnings Buzz and Dividend Talk
Hey there! It’s Joey, your friendly longtime investor, here to break down the day. Today we’re chatting about Pfizer, and guess what? It was a green day, up about 2.9%. Not too shabby!So, what went down? Pfizer’s stock got a nice little boost, and it seems like folks are feeling a bit more optimistic. There’s a buzz around their upcoming earnings report, which is always a big deal. Plus, the chatt

PFE Today - Jul 27: FDA Review Sparks Interest
Hey there! It’s Joey here, your friendly stock enthusiast, and I've been in the investing game for years. Today, we're talking about Pfizer, and it was a bit of a green day for them, up just a smidge by about 0.81%. So, what happened? Well, the stock saw some movement, but nothing wild. It was mostly stable, hanging around that $24.74 mark. There was some buzz in the air, though, thanks to the FDA

PFE Today - Jul 26: Lung Cancer Trial Disappointment
Hey, what’s up? It’s Joey here, your friendly investor buddy. Just breaking down the day for you. Today, we're talking about Pfizer, and it was a red day—down about 1.9%. Ouch!So here’s the scoop. Pfizer's stock took a hit today, and honestly, it got smoked. The main reason? They had some disappointing news from a lung cancer trial. Investors were expecting big things, but when the results came in

PFE Today - Jul 25: Lung Cancer Trial Disappointment
Hey there! It’s Joey, your friendly neighborhood investor, and I’m here to break down what went down with Pfizer today. So, PFE had a rough day, dropping about 1.9%. Yeah, that one stung.Here’s the scoop: Pfizer’s stock got smoked because of some disappointing news from a lung cancer trial. Investors were really hoping for a win there, but it didn’t pan out, and that sent people racing for the exi

PFE Today - Jul 24: Dividend Yield Concerns
Hey there! It’s Joey here, your friendly longtime investor, breaking down today’s stock action. Let’s talk about Pfizer. It was a red day for them, down about 1.6%. Yeah, that one stung.So, what happened? The stock took a hit, and honestly, it seemed like a mix of concerns swirling around. Investors are chatting about that juicy 7% dividend yield Pfizer's throwing out there. Sounds great, right? B

PFE Today - Jul 23: Mixed News and Lawsuits
Hey there! It’s Joey here, your friendly investor buddy, breaking down what went down today with Pfizer. So, PFE had a pretty chill day, not much action, just up a tiny bit—like 0.4%. So here’s the scoop. Pfizer’s been in the news lately, and not all of it’s been sunshine and rainbows. They’re facing some expanded lawsuits over their vaccine stuff. Yeah, that one stung a little. It’s creating some

PFE Today - Jul 22: Steady Day Amid Mixed News
Hey there! It’s Joey, your friendly longtime investor here, breaking down what went down with Pfizer today. So, PFE had a pretty chill day, barely moving, just up a little over half a percent. Not exactly fireworks, but hey, at least it didn’t tank, right?So, here’s the scoop. The stock’s been kind of steady lately, which is a nice change of pace given how wild it can get. Today, it was all about

PFE Today - Jul 21: Steady Day for Pfizer
Hey there! I'm Joey, your friendly stock buddy who's been in the investing game for a while. Today, we’re chatting about Pfizer, and it was a pretty chill day for them—up just a smidge at 0.87%. Not a wild ride, but hey, it’s something!So, what happened? Pfizer's stock stayed pretty steady today, barely moving around the $25 mark. It wasn't like it got smoked or anything, just a slow bleed. The vo

PFE Today - Jul 20: Vaccine Efficacy News
Hey there! It’s Joey here, your friendly investor buddy, and I’m breaking down what went down with Pfizer today. So, we’re talking about PFE, and it had a bit of a red day, down about half a percent. So, what happened? Well, the stock kinda cruised through the day but didn’t make any big moves. It’s like it was just chilling, you know? It opened and closed around the same price, barely budging at

PFE Today - Jul 19: Mixed Results for Cancer Drug
Hey there! It’s Joey here, your friendly investor buddy, breaking down today’s stock moves. Today, we’re talking about Pfizer, and it was a bit of a red day for them, down just a smidge, like 0.36%. So, here’s the scoop. Pfizer's stock kinda hung around, not making any big waves. The volume was steady, but there wasn't much excitement. They dropped some mixed results related to a cancer drug they’

PFE Today - Jul 18: Mixed News, Slight Drop
Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for you. Today we’re talking about Pfizer, and it was a bit of a red day for them, down just a smidge. So, here’s the scoop. PFE dropped about 0.36%. Not a huge hit, but enough to make you raise an eyebrow. Trading was pretty active too, with a good chunk of shares changing hands, but it still felt like a slow bl

PFE Today - Jul 17: FDA Approval Hype Fades
Hey there! It’s Joey, your friendly neighborhood investor, here to break down what happened with Pfizer today. So, let’s talk about PFE – it was a bit of a mixed bag today, but overall, it ended up in the green, gaining about 0.84%. Not a huge jump, but hey, at least it wasn't a total disaster, right?Now, here’s the scoop: there was some buzz around Pfizer getting a new FDA approval for a bladder

PFE Today - Jul 16: Mixed Results Impact Stock
Hey there! It's Joey, your friendly longtime investor, here to break down what happened with Pfizer today. So, PFE had a green day, up about 1.69%. Not too shabby, right?But here’s the scoop: the stock was reacting to some mixed news. There were these topline results for a cancer drug developed with Seagen, and honestly, the info was all over the place. Some folks were excited, but others were scr

PFE Today - Jul 15: Bearishness Sparks Conversations
Hey there! It’s Joey, your friendly longtime investor, breaking down the stock scene for you. Today, we’re talking about Pfizer, and it was a green day for them—up about 1.36%. Not a massive jump, but hey, we’ll take what we can get, right?So, what happened? Well, Pfizer managed to bounce back a bit today after a rough patch. After taking a hit recently, the stock saw some nice movement, but let’s

PFE Today - Jul 14: Drug Pricing Deals Impacting Pfizer
Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Pfizer today. So, PFE had a red day, dropping about 0.8%. Ouch, right?Let’s get into it. Today was a bit rough for Pfizer. The stock got hit as news rolled in about drug pricing deals from Donald Trump that are shaking things up for big pharma. Investors were clearly feeling the weight of that news. P

PFE Today - Jul 13: Price Target Cuts Hit Hard
Hey there! It's Joey, your friendly investor buddy, breaking down what went down today with Pfizer. So, PFE had a bit of a green day, up about 1.82%. Not too shabby, right?But hold on, it wasn’t all sunshine and rainbows. The stock kinda had a rough ride earlier in the week. Today’s uptick was like a small bounce back after some recent price target cuts from analysts. Guggenheim lowered its target

PFE Today - Jul 12: Lung Cancer Trial Disappointment
Hey there! It’s Joey, your friendly neighborhood investor, here to break down what happened today with Pfizer. So, PFE had a red day, dropping about a third of a percent. Nothing too crazy, but still not great.What went down? Well, it looks like folks are still feeling the sting from some disappointing news about a lung cancer trial. Yeah, that one stung. People were really hoping for a win there,

PFE Today - Jul 11: Pfizer's Slow Day
Hey, what’s up? It’s Joey here, your friendly neighborhood investor, breaking down the day’s action. Today, we’re talking about Pfizer. It was a bit of a rough ride, closing down just a smidge—like, down 0.33%. Yeah, that one stung a little.So, what went down? Well, the stock kinda just sat there, barely moving. It wasn’t a huge day for trading, with volume coming in lower than usual. Just 27 mill

PFE Today - Jul 10: Mixed Signals in Pharma
Hey there! It’s Joey here, your go-to guy for breaking down the stock scene. I’ve been at this investing game for years, and today we’re talking about Pfizer. So, was it a green or red day? Well, it was a slight red day, down just a smidge—like, 0.08%. Now, what happened? The stock kinda just floated around. It didn’t really get smoked, but it also didn’t pop off. Volume was way lower than usual,

PFE Today - Jul 09: AstraZeneca's Crash Boosts Rivals
Hey there! It’s Joey, your friendly investor buddy. Let’s break down what went down with Pfizer today. So, PFE had a pretty chill day, closing up just a little, like 0.54%. Not exactly fireworks, but hey, it’s something, right?So, here’s the scoop. Pfizer didn’t have a huge move on its own, but it kinda rode the coattails of AstraZeneca’s rough day. AstraZeneca took a dive, crashing about 8%. That

PFE Today - Jul 09: AstraZeneca Drama Boosts Rivals
Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Pfizer today. So, we’re talking about PFE, and it had a green day, up just a bit by about half a percent. Not a huge jump, but hey, green is good!Now, here’s the scoop. Pfizer started the day kinda slow but picked up some steam after some news about AstraZeneca. They took a hit, dropping about 8%. That news

PFE Today - Jul 08: Market Gains, Pfizer Sinks
Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while now, and today we’re talking about Pfizer, ticker PFE. So, was it a green day or a red day? Well, it was a bit of a bummer—Pfizer dipped by a tiny bit, down 0.08%. Yeah, that one stung.So, what happened? The stock got smoked today, even while the overall market was doing pretty well. It’s like Pfizer

PFE Today - Jul 07: HSBC Downgrades Pfizer Stock
Hey there! It’s Joey, your friendly neighborhood investor. I’ve been in the game for a while, and today I’m breaking down Pfizer. So, PFE had a bit of a mixed bag today, closing down about 1.6%. Now, let’s talk about what went down. The stock got hit hard after HSBC decided to downgrade it. Yeah, that one stung. They basically said there’s not much happening in the near term for Pfizer that would

PFE Today - Jul 06: HSBC Downgrades Pfizer Stock
Hey there! It's Joey here, your friendly neighborhood investor, breaking down today’s stock action. Today, we’re chatting about Pfizer, and it was a red day for them—down about 2.6%. Ouch.So, what happened? Well, Pfizer got smoked today, and a big part of that was HSBC downgrading their stock rating. They basically said there’s a lack of near-term catalysts to get the stock moving in a positive di
Recommended

صداستان: ساعتی با موسیقی

Becoming: HER with Nikki Spoelstra

Exposing Workplace Bullying

Everyday AI Made Simple - AI For Everyday Tasks

FemTech Focus

Not Too Sensitive - Empowering Highly Sensitive People (HSPs) To Own Their Sensitivity

Mother Daughter Relationship Show

Skin Deep MDs with Dr. Mamina Turegano, Dr. Lindsey Zubritsky and Dr. Jenny Liu

girl talk 🎧🫧

Booked, Blonde & Busy w/ Olivia Ponton

LOVE SOMEONE with Delilah

Classical Christian Education